🇺🇸 Immunochemotherapy in United States

19 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Neutropenia — 5 reports (26.32%)
  2. Thrombocytopenia — 5 reports (26.32%)
  3. Myelodysplastic Syndrome — 2 reports (10.53%)
  4. Blood Culture Positive — 1 report (5.26%)
  5. Coma — 1 report (5.26%)
  6. Cytomegalovirus Test Positive — 1 report (5.26%)
  7. Diabetic Hyperosmolar Coma — 1 report (5.26%)
  8. Diffuse Large B-Cell Lymphoma — 1 report (5.26%)
  9. Encephalitis Viral — 1 report (5.26%)
  10. Staphylococcal Bacteraemia — 1 report (5.26%)

Source database →

Other Immunology approved in United States

Frequently asked questions

Is Immunochemotherapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Immunochemotherapy in United States?

Jianxing He is the originator. The local marketing authorisation holder may differ — check the official source linked above.